New scan technique aims to predict breast cancer therapy outcomes
NCT ID NCT07419867
First seen Feb 20, 2026 · Last updated Jun 19, 2026 · Updated 15 times
Summary
This study tests whether special PET/MRI scans using different tracers can predict how well breast cancer treatments work. Researchers will scan 300 women before and after two cycles of therapy. The goal is to find which scans best signal treatment success, helping future patients get the right therapy faster.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, 200032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PET/MRI with specific tracers (18F-FDG, HER2, FAPI)
What this could lead to
If successful, this could help doctors quickly see if a breast cancer treatment is working, leading to more personalized and effective care.
What could go wrong
This is an early exploratory study, not testing a new treatment itself. The results may not lead to immediate changes in patient care.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.